Human Guanylate cyclase soluble subunit alpha-1 582-589, SVFAGVVGV
Description
About Human Guanylate cyclase soluble subunit alpha-1 582-589, SVFAGVVGV
The Human Guanylate cyclase soluble subunit alpha-1 Peptide (IEDB: 637510) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Guanylate cyclase Peptide, H-SVFAGVVGV-OH (Uniprot: Q02108 aa: 582-589) from JPT is produced under strict quality control and quality management.
Human Guanylate cyclase soluble subunit alpha-1 582-589, SVFAGVVGV - Specifications
- Peptide sequence: H-SVFAGVVGV-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Breast cancer
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human Guanylate cyclase soluble subunit alpha-1 582-589, SVFAGVVGV
References:
Read References with JPT’s Antigen Peptides
Human Guanylate cyclase soluble subunit alpha-1 582-589, SVFAGVVGV has been described in:
Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction., Immunity, 2017 (PMID: 28228285)
Immunopeptidomic Profiling of HLA-A2-Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens., Proteomics, 2018 (PMID: 29786170)
Documentation
Documentation for Human Guanylate cyclase soluble subunit alpha-1 582-589, SVFAGVVGV
Properties
Properties of Human Guanylate cyclase soluble subunit alpha-1 582-589, SVFAGVVGV
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Breast cancer |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | Guanylate cyclase |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human Guanylate cyclase soluble subunit alpha-1 582-589, SVFAGVVGV
Information | Values |
---|---|
Sequence: | H-SVFAGVVGV-OH |
Specifications: | 9mer peptide as TFA salt |